Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer20 Oct ETF OCTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Sell
45,558
-820
-2% -$33K ﹤0.01% 1743
2026
Q1
$1.78M Sell
46,378
-2,599
-5% -$101K ﹤0.01% 1680
2025
Q4
$1.91M Buy
48,977
+6,164
+14% +$238K 0.01% 1559
2025
Q3
$1.64M Buy
42,813
+492
+1% +$18.6K ﹤0.01% 1657
2025
Q2
$1.57M Sell
42,321
-9,992
-19% -$355K ﹤0.01% 1616
2025
Q1
$1.84M Buy
52,313
+20,123
+63% +$718K 0.01% 1409
2024
Q4
$1.15M Buy
32,190
+2,591
+9% +$91.8K ﹤0.01% 1757
2024
Q3
$1.04M Sell
29,599
-630
-2% -$21.9K ﹤0.01% 1833
2024
Q2
$1.04M Sell
30,229
-1,005
-3% -$34.3K ﹤0.01% 1746
2024
Q1
$1.06M Hold
31,234
﹤0.01% 1695
2023
Q4
$1.02M Buy
31,234
+9,197
+42% +$292K ﹤0.01% 1643
2023
Q3
$685K Sell
22,037
-11,579
-34% -$356K ﹤0.01% 1830
2023
Q2
$1.02M Sell
33,616
-15,646
-32% -$464K ﹤0.01% 1598
2023
Q1
$1.44M Sell
49,262
-6,363
-11% -$182K 0.01% 1337
2022
Q4
$1.55M Buy
55,625
+16,145
+41% +$446K 0.01% 1236
2022
Q3
$1.06M Buy
39,480
+15,402
+64% +$411K 0.01% 1434
2022
Q2
$629K Buy
24,078
+2,631
+12% +$70.3K ﹤0.01% 1788
2022
Q1
$590K Buy
21,447
+3,943
+23% +$107K ﹤0.01% 1971
2021
Q4
$485K Buy
+17,504
New +$480K ﹤0.01% 2127

Other funds holding OCTW

Cambridge Investment Research Advisors's OCTW Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its AllianzIM U.S. Equity Buffer20 Oct ETF (OCTW) stake by 1.8% in Q2 2026, selling an estimated $33K and leaving 45,558 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Cambridge Investment Research Advisors first reported a position in OCTW in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.91M in Q4 2025. 34 funds tracked by Wall St. Rank hold OCTW as of Q2 2026.

  • Cambridge Investment Research Advisors held 45,558 shares of AllianzIM U.S. Equity Buffer20 Oct ETF worth $1.86M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 820 AllianzIM U.S. Equity Buffer20 Oct ETF shares in Q2 2026, an estimated $33K.
  • AllianzIM U.S. Equity Buffer20 Oct ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1743 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer20 Oct ETF in Q4 2021 and has held it in 19 quarters since.
  • Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer20 Oct ETF position peaked at $1.91M in Q4 2025.
  • 34 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Oct ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.